VALUTAZIONE DELLO STATO IPERCOAGULATIVO IN UNA CASISTICA DI SOGGETTI A RISCHIO: STUDIO DI ALCUNI MARKERS PRETROMBOTICI

Translated title of the contribution: Prethrombotic markers in leukemic patients: Comparison of three tests

F. Cerneca, O. Radillo, R. Simeone, S. De Luyk, M. Mangiarotti

Research output: Contribution to journalArticle

Abstract

We studied three immunoenzymatic techniques designed to evaluate an hypercoagulability status in a group of young leukemic patients (N = 40: age 3-16, sex: 17 F, 23 M) versus a control group of the same age and sex (N = 80; age 5-18, sex: 45 F, 35 M). Our aim was to choose the test that most specifically evidenciates an imbalancement in coagulation homeostasis in leukemic patients treated with L-asparaginase. We performed on our samples the following determinations: prothrombin fragment F1 + 2 (F1 + 2), thrombin-antithrombin complex (TAT), modified antithrombin III (ATM). The precision was satisfactory for each of the three tests, with a CV ranging from 4 to 7%. Pearson's correlation coefficient (r) was determined matching each test versus the other ones. The correlation is highly significant for TAT versus F1 + 2 (r = 0.9165), while it is not so high for TAT versus ATM (r = 0.7972) and F1 + 2 versus ATM (r = 0.7681). The mean values (± 2 SD) for each of the three tests performed on leukemic patients were significantly different (P <0.05) from those of control group. Among our leukemic L-asparaginase treated patients we could observe two cases of thrombosis, which were preceded by a significant increase of the tests hereby described.

Original languageItalian
Pages (from-to)105-110
Number of pages6
JournalGiornale Italiano di Chimica Clinica
Volume18
Issue number2
Publication statusPublished - 1993

Fingerprint

Antithrombin III
Asparaginase
Prothrombin
Coagulation
Control Groups
Thrombophilia
Thrombosis
Homeostasis
antithrombin III-protease complex

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

VALUTAZIONE DELLO STATO IPERCOAGULATIVO IN UNA CASISTICA DI SOGGETTI A RISCHIO : STUDIO DI ALCUNI MARKERS PRETROMBOTICI. / Cerneca, F.; Radillo, O.; Simeone, R.; De Luyk, S.; Mangiarotti, M.

In: Giornale Italiano di Chimica Clinica, Vol. 18, No. 2, 1993, p. 105-110.

Research output: Contribution to journalArticle

@article{ddf62be9684e45e887a85b634d507884,
title = "VALUTAZIONE DELLO STATO IPERCOAGULATIVO IN UNA CASISTICA DI SOGGETTI A RISCHIO: STUDIO DI ALCUNI MARKERS PRETROMBOTICI",
abstract = "We studied three immunoenzymatic techniques designed to evaluate an hypercoagulability status in a group of young leukemic patients (N = 40: age 3-16, sex: 17 F, 23 M) versus a control group of the same age and sex (N = 80; age 5-18, sex: 45 F, 35 M). Our aim was to choose the test that most specifically evidenciates an imbalancement in coagulation homeostasis in leukemic patients treated with L-asparaginase. We performed on our samples the following determinations: prothrombin fragment F1 + 2 (F1 + 2), thrombin-antithrombin complex (TAT), modified antithrombin III (ATM). The precision was satisfactory for each of the three tests, with a CV ranging from 4 to 7{\%}. Pearson's correlation coefficient (r) was determined matching each test versus the other ones. The correlation is highly significant for TAT versus F1 + 2 (r = 0.9165), while it is not so high for TAT versus ATM (r = 0.7972) and F1 + 2 versus ATM (r = 0.7681). The mean values (± 2 SD) for each of the three tests performed on leukemic patients were significantly different (P <0.05) from those of control group. Among our leukemic L-asparaginase treated patients we could observe two cases of thrombosis, which were preceded by a significant increase of the tests hereby described.",
keywords = "hypercoabulability, leukemia, modified antithrombin III, prothrombin fragment F1 + 2, thrombin-antithrombin III complex",
author = "F. Cerneca and O. Radillo and R. Simeone and {De Luyk}, S. and M. Mangiarotti",
year = "1993",
language = "Italian",
volume = "18",
pages = "105--110",
journal = "Giornale Italiano di Chimica Clinica",
issn = "0392-2227",
publisher = "Piccin Editore",
number = "2",

}

TY - JOUR

T1 - VALUTAZIONE DELLO STATO IPERCOAGULATIVO IN UNA CASISTICA DI SOGGETTI A RISCHIO

T2 - STUDIO DI ALCUNI MARKERS PRETROMBOTICI

AU - Cerneca, F.

AU - Radillo, O.

AU - Simeone, R.

AU - De Luyk, S.

AU - Mangiarotti, M.

PY - 1993

Y1 - 1993

N2 - We studied three immunoenzymatic techniques designed to evaluate an hypercoagulability status in a group of young leukemic patients (N = 40: age 3-16, sex: 17 F, 23 M) versus a control group of the same age and sex (N = 80; age 5-18, sex: 45 F, 35 M). Our aim was to choose the test that most specifically evidenciates an imbalancement in coagulation homeostasis in leukemic patients treated with L-asparaginase. We performed on our samples the following determinations: prothrombin fragment F1 + 2 (F1 + 2), thrombin-antithrombin complex (TAT), modified antithrombin III (ATM). The precision was satisfactory for each of the three tests, with a CV ranging from 4 to 7%. Pearson's correlation coefficient (r) was determined matching each test versus the other ones. The correlation is highly significant for TAT versus F1 + 2 (r = 0.9165), while it is not so high for TAT versus ATM (r = 0.7972) and F1 + 2 versus ATM (r = 0.7681). The mean values (± 2 SD) for each of the three tests performed on leukemic patients were significantly different (P <0.05) from those of control group. Among our leukemic L-asparaginase treated patients we could observe two cases of thrombosis, which were preceded by a significant increase of the tests hereby described.

AB - We studied three immunoenzymatic techniques designed to evaluate an hypercoagulability status in a group of young leukemic patients (N = 40: age 3-16, sex: 17 F, 23 M) versus a control group of the same age and sex (N = 80; age 5-18, sex: 45 F, 35 M). Our aim was to choose the test that most specifically evidenciates an imbalancement in coagulation homeostasis in leukemic patients treated with L-asparaginase. We performed on our samples the following determinations: prothrombin fragment F1 + 2 (F1 + 2), thrombin-antithrombin complex (TAT), modified antithrombin III (ATM). The precision was satisfactory for each of the three tests, with a CV ranging from 4 to 7%. Pearson's correlation coefficient (r) was determined matching each test versus the other ones. The correlation is highly significant for TAT versus F1 + 2 (r = 0.9165), while it is not so high for TAT versus ATM (r = 0.7972) and F1 + 2 versus ATM (r = 0.7681). The mean values (± 2 SD) for each of the three tests performed on leukemic patients were significantly different (P <0.05) from those of control group. Among our leukemic L-asparaginase treated patients we could observe two cases of thrombosis, which were preceded by a significant increase of the tests hereby described.

KW - hypercoabulability

KW - leukemia

KW - modified antithrombin III

KW - prothrombin fragment F1 + 2

KW - thrombin-antithrombin III complex

UR - http://www.scopus.com/inward/record.url?scp=0027853155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027853155&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0027853155

VL - 18

SP - 105

EP - 110

JO - Giornale Italiano di Chimica Clinica

JF - Giornale Italiano di Chimica Clinica

SN - 0392-2227

IS - 2

ER -